Bleakley Financial Group LLC Sells 11,082 Shares of Cencora, Inc. $COR

Bleakley Financial Group LLC lowered its stake in shares of Cencora, Inc. (NYSE:COR) by 39.4% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 17,020 shares of the company’s stock after selling 11,082 shares during the period. Bleakley Financial Group LLC’s holdings in Cencora were worth $5,347,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in COR. Kemnay Advisory Services Inc. purchased a new position in Cencora during the 4th quarter valued at about $25,000. Oakworth Capital Inc. purchased a new stake in shares of Cencora in the fourth quarter worth about $26,000. Elyxium Wealth LLC purchased a new stake in shares of Cencora in the fourth quarter worth about $27,000. Archer Investment Corp boosted its position in shares of Cencora by 134.3% in the fourth quarter. Archer Investment Corp now owns 82 shares of the company’s stock valued at $28,000 after acquiring an additional 47 shares during the period. Finally, Motiv8 Investments LLC bought a new position in shares of Cencora in the fourth quarter valued at approximately $29,000. 97.52% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research firms recently weighed in on COR. William Blair started coverage on shares of Cencora in a report on Tuesday, April 28th. They set a “market perform” rating on the stock. Evercore set a $360.00 price target on shares of Cencora in a report on Wednesday, April 8th. Citigroup reduced their price target on shares of Cencora from $405.00 to $355.00 and set a “buy” rating for the company in a research report on Thursday, May 7th. Weiss Ratings cut shares of Cencora from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, June 30th. Finally, Leerink Partners reiterated an “outperform” rating on shares of Cencora in a research report on Tuesday, March 17th. Eleven research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, Cencora presently has a consensus rating of “Moderate Buy” and an average price target of $367.75.

Insider Activity

In other news, Director Lauren M. Tyler acquired 550 shares of the business’s stock in a transaction dated Monday, June 22nd. The stock was purchased at an average cost of $270.23 per share, for a total transaction of $148,626.50. Following the acquisition, the director owned 4,359 shares of the company’s stock, valued at $1,177,932.57. This trade represents a 14.44% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders own 0.38% of the company’s stock.

Cencora Stock Performance

Cencora stock opened at $302.16 on Wednesday. Cencora, Inc. has a fifty-two week low of $244.82 and a fifty-two week high of $377.54. The company has a debt-to-equity ratio of 3.40, a quick ratio of 0.59 and a current ratio of 0.95. The stock has a market cap of $58.79 billion, a P/E ratio of 23.17, a price-to-earnings-growth ratio of 1.70 and a beta of 0.58. The firm’s fifty day moving average price is $277.12 and its 200-day moving average price is $318.31.

Cencora (NYSE:COR) last announced its earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.82 by ($0.07). The company had revenue of $78.36 billion during the quarter, compared to analysts’ expectations of $81.09 billion. Cencora had a return on equity of 135.20% and a net margin of 0.78%.The firm’s revenue was up 3.9% on a year-over-year basis. During the same quarter last year, the firm posted $4.42 earnings per share. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. On average, equities research analysts expect that Cencora, Inc. will post 17.79 earnings per share for the current fiscal year.

Cencora Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were paid a dividend of $0.60 per share. The ex-dividend date of this dividend was Friday, May 15th. This represents a $2.40 annualized dividend and a yield of 0.8%. Cencora’s payout ratio is 18.40%.

Cencora announced that its board has authorized a share buyback program on Thursday, May 21st that permits the company to repurchase $2.00 billion in shares. This repurchase authorization permits the company to buy up to 3.9% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s board of directors believes its stock is undervalued.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.